Objective: To assess the antioxidant/non-antioxidant effects of a hydroxytyrosol (HT)-rich phenolic extract from olive mill wastewaters administered with a breakfast. Design, setting and subjects: Five type I diabetic patients received 25 mg of HT the first day and 12.5 mg/day the following 3 days. Blood sampling was carried out at T 0 (baseline) and T 4d just before the breakfast þ HT administration and at time points 1, 2, 3 and 4 h after T 0 . Urines (24-h) were collected from T 0 to T 4d . Baseline HbA1c was generally inferior to 10%, glycemia was within the range 6-24 mmol/l, whereas total cholesterol, HDL-chol and triglycerides were normal. Results: The major finding was the 46% decrease in the serum TXB 2 production after blood clotting at T 4d . Plasma vitamin A, E, b-carotene were not changed. Vitamin C tended to increase (P ¼ 0.075). Plasma antioxidant capacity was enhanced at T 0 þ 1 h only, whereas its main determinants (albumin, bilirubin, uric acid) were not modified. Urinary 8-isoPGF 2a levels were highly variable and were not affected significantly by HT administration. Conclusion: The major effect of HT accounts for an antiaggregating platelet action, leading to a possible prevention of thrombotic and microthrombotic processes. 
Introduction
Nutritional intervention studies have already shown the beneficial effects of olive oil towards cholesterolemia and LDL oxidizability in humans (Visioli & Galli, 2001; Léger, 2003) . These effects are not explained only by the oleic acid substitution to saturated (for cholesterolemia) or polyunsaturated (for oxidizability) fatty acids. Polyphenols from olive or olive oil are potentially able to protect LDL against oxidation by enhancing the antioxidant defense of LDL (Fito et al, 2000; Masella et al, 2001) , regardless of the oxidationgenerating system (Shafiee et al, 2003) . It is likely that this LDL protecting effect is due to a systemic general antioxidant effect accounted for by the decrease in urinary excretion of 8-iso PGF 2a (Visioli et al, 2000a) . Hydroxytyrosol (HT) is mainly responsible for antioxidant capacities of olive fruit and olive oil polyphenolic extracts (Soler-Rivas et al, 2000) . The HT bioavailability has been established (Visioli et al, 2000b; Miro-Casas et al, 2001) . Olive oil wastewaters polyphenolic extracts protect LDL against oxidation ex vivo (Visioli et al, 1998) . They may also exhibit cell-mediated antioxidant and non-antioxidant effects (Visioli et al, 1999; Léger et al, 2000) . The physiological relevance of these properties remains to be explored in humans.
The purpose here was to assess the effect of a HT preparation on the oxidative and nonoxidative status of type I diabetic patients who are known to be exposed to an early atherogenic process, a rapid development of advanced atherosclerotic lesions and lipid peroxidation (Feener & King, 1997) . Some of the present data were already published in the form of an abstract (Léger et al, 2002) .
Methods
This study was approved by the Ethic Committee of the Lapeyronie Hospital of Montpellier.
Five 32-68-y-old male patients were recruited after giving a written informed consent. They were affected by type I diabetes according to the definition of the WHO, under recurrent insulin treatment with a HbA1c content usually lower than 10%.
Patients were administered a HT-concentrated extract obtained from olive oil wastewaters, which in turn were obtained from freshly ground olives (Visioli et al, 1999; Léger et al, 2000) . The liquid (glycerol/water) HT-rich extract was composed of HT (53%) and tyrosol (13%) in the free form on the one hand, elenolic acid and elenolic acid derivatives (34%) on the other. The HT content of the liquid extract was adjusted to 10 mg/ml. This preparation was administered once mixed with a yogurt containing either 25 or 12.5 mg of HT.
For 5 days before administration, the patients were asked to strictly follow dietary instructions: no wine, citrus fruit, cola, vitamins or bioactive-related products in the form of supplement, edible oil rich in vitamin E, olive oil and no more than one coffee or tea per day. For 10 days before study, they were also asked not to consume paracetamol-and acetylsalicylate-containing drugs. The experimental sequence was scheduled to last 4 days. The liquid extract was administered during the breakfast at the following time points: T 0 , T 1d , T 2d , T 3d , after introducing into a yogurt. Yogurts containing 25 mg HT were administered at T 0 , whereas those containing 12.5 mg HT were administered at T 1d , T 2d , and T 3d . Breakfast consisted in cheese (50 g), rusks (6), jam (30 g) and butter (20 g), providing a total enegy intake of 2370 kJ (567 kcal). Blood samples were drawn by venepuncture on 1 g/l EDTA at T 0 and T 4d just before the breakfast in overnight fasting condition. The aforementioned dietary restrictions were maintained during the period of extract administration and blood sampling. In addition, four blood samples were collected 1, 2, 3, and 4 h after the first extract administration, whereas 24-h urine samples were collected during the last 24 h before T 0 , T 1d , T 2d , T 3d , and T 4d . 8-isoPGF 2a (updated name: iPF 2a -III) was determined as follows. Acidified 24-h urine samples (10 ml) were added with 3 H-8-isoPGF 2a as internal standard (Cayman Chemicals, SPI-BIO, Massy, France), and treated by two extractions using successively an inverse-phase and an aminopropyl-phase cartridge (SepPak VACRC C-18 and VACRC NH2, Waters SA, Guyancourt, France) according to Bessard et al (2001) . EIA procedure was carried out by means of the 8-isoprostane EIA Kit from Cayman Chemicals with the following main crossed reactions: 8-isoPGF 3a (21%) and 8-isoPGE 2 (1.8%). There were no nonspecific binding reactions. TXB 2 was assayed on the whole serum after a 30-min blood clotting by means of the TXB 2 EIA Kit (Cayman Chemicals) with the following mean crossed reactions: 2,3-dinor-TXB 2 (56%) and TXB 3 (30%). Glycemia, HbA1c, total cholesterol, HDL cholesterol, triglycerides, uric acid, bilirubin and creatinine were assayed according to routine procedures in the Department of Biochemical Analyses of the Lapeyronie Hospital (Montpellier, France). Plasma vitamin E and C determinations were carried out as already described (Cachia et al, 1995; Birlouez-Aragon et al, 2001 ). b-Carotene was assayed by using the reagent kit for HPLC analysis from ChromSystems (München, Germany). The pAOC determination procedure has recently been described extensively (Cartron et al, 2003) . Statistical analyses were performed by means of the Wilcoxon rank sum test by the StatView F4-5 software (Abacus Concepts, Berkeley, CA, USA). Significant differences are those for Po0.05. Results were expressed as means7s.e.m.
Results and discussion
Glycemia and HbA1c of the five patients were indicative of a diabetic status (13.072.8 mmol/l and 8.670.6%, respectively), whereas lipid characteristics were within normalcy (total cholesterol, 1.7970.11 g/l; HDL-cholesterol, 0.5670.05 g/l; triglycerides, 0.8270.14 g/l). There was no significant modification of plasma biochemical characteristics due to the experimental treatment (i.e. T 4d vs T 0 ) and values were within the range of reference values. It is worth mentioning that patients showed low levels of vitamin C at T 0 (ranging from 14.3 to 35.2 mmol/l), and a tendency to increased levels at T 4d (P ¼ 0.075), but no change took place for other pAOC determinants (albumin, bilirubin, uric acid). Urine isoprostane excretion after creatinine normalization was not modified by the treatment either (Figure 1 ) and showed a fairly high interindividual variability at all sampling times. A significant change in pAOC values was found between T 0 and T 0 þ 1 h ( þ 26.976.7%, mean7 s.e.m., Po0.02) and no change was observed at T 2h , T 3h , T 4h , and T 4d . Most importantly, a significant decrease in the TXB 2 release was found (Figure 2) at T 4d as compared to T 0 (À46.8710.9%, Po0.02).
As a general consideration, it is presently allowed to assume that HT administration is equivalent to 25-50 g of olive fruit (see, for example, the coratina variety reported by Esti et al, 1998) , that is, approx. 15 olives on the first day of administration, and seven to eight olives the following 3 days . This administration pattern has been chosen for being representative of a consumption considered conventional in some countries of the Southern Europa.
A growing interest is attributed to polyphenols of natural origin as healthy and bioactive compounds in general. A special attention has been dedicated to olive polyphenols, since one part of the beneficial effect of olive oil could be attributed to its polyphenol fraction (Léger, 2003) . Recently, Visioli et al (2000a) have been able to show that increasing doses of an olive oil polyphenol extract added to a phenolpoor olive oil were responsible for a decrease in 8-isoPGF 2a urinary excretion in healthy volunteers. The present results did not confirm this effect although (1) administered doses of HT were three to seven times as high, and (2) basal 8-isoPGF 2a excretion levels were approximately three times as high. Such a discrepancy cannot be attributed to the form of administration since HT urinary excretion has been shown to be similar when administered HT was mixed with a yogurt and added to a refined (phenol-free) olive oil (Visioli et al, 2003) . However, it could be attributed to the administered amounts of total phenolic compounds since the decreased isoprostane urinary excretion was obtained for a total amount of phenolic compounds at least equal to 48.7 mg, an amount which was much higher than the highest dose of HT presently administered as unique phenolic compound. This would mean that phenolic compounds other than HT participate in decreasing urinary isoprostanes. Future investigations need to clarify this point.
The validity of pAOC as a total antioxidant status biomarker is generally considered nonconvincing (RiceEvans, 2000). To some extent, validity could be improved when variation of its main determinants is taken into account, as it was the case here. We only found a transient and significant increase in plasma antioxidant protection 1 h after HT administration, not depending on its determinants albumin, uric acid and bilirubin, suggesting that this effect was due to HT intake. Moreover, this effect might be underestimated because it has been established that pAOC decreases just after a meal, due to the postprandial lipemiaassociated oxidative stress (Cartron et al, 2003) . A similar (but not statistically significant) transient effect was shown in rats (Visioli & Galli, 2001) . That plasma vitamin C tended to increase at T 4d was of interest but has to be confirmed. This would be the sign that the HT-rich extract exerted a vitamin C sparing effect due to a physiologically relevant antioxidant role in plasma.
A considerable decrease in the release of TXB 2 was found at T 4d . It is well known that TXB 2 is the chemically stable form deriving from TXA 2 and indicative of the aggregating function of platelets. The present assessing procedure took advantage of the generation of endogenous thrombin after blood clotting (Patrono et al, 1980) . Finding was in line with the in vitro antiaggregatory effect of HT in human platelet-rich plasma (Petroni et al, 1995; Bermejo Benito et al, 2000) , but in contrast with other results showing no HT inhibition of TXB 2 generation in rat peritoneal leukocytes at physiologically compatible concentrations (De la Puerta et al, 1999) . More recently, Visioli et al (2004) have shown that an administration of 6.6 mg/day of HT for 49 days was able to decrease TXB 2 by 21%, confirming the present results. However, it appears clearly from the present intervention that the HT-elicited decrease occurs very rapidly. In other respects, it is worth emphasizing that magnitude of the TXB 2 decrease presently found in vivo can readily be considered indicative of a change in platelet function, resulting in a beneficial effect in thrombo-ischemic processes. This could be of particular interest to prevent thrombosis and microthrombosis in diabetic patients since a platelet hyperfunction could still occur in the case of an efficiently controlled glycemia by therapeutic approach (Kajita et al, 2001 ). However, the rationale for this thromboxane effect remains unexplained.
Taken together, these findings strongly suggest that a HT-rich extract exhibits a cell-mediated effect in vivo at nutritional doses, whereas its direct antioxidant effect is still far from being demonstrated. acid metabolism in cellular systems. Planta Med. 66, 324-328. 
